Company / Operating Cash Flow per Share
Phio Pharmaceuticals Corp. Operating Cash Flow per Share History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$12.91
FY2020
5-year range
-$21.95 / -$1.12
FY2016-FY2020
Trend
+41.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-21.95 in FY2019 to $-0.05 in FY2012.
Based on SEC 10-K filings.
-12.91 in FY2020.
Declined from $-3.92 to $-12.91 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating cash flow per share increased 41.2% year-over-year.
- Peak operating cash flow per share was recorded in FY2012.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$12.91 | +41.2% |
| FY2019 | -$21.95 | -460.7% |
| FY2018 | -$3.92 | +34.4% |
| FY2017 | -$5.97 | -433.0% |
| FY2016 | -$1.12 | -17.0% |
| FY2013 | -$0.96 | -1799.0% |
| FY2012 | -$0.05 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026